UK markets closed

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.33-0.54 (-9.20%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
-5,871
-5,871
-7,446
-1,347
-812.371
Depreciation & amortisation
769.687
769.687
604.397
26.456
9.516
Stock-based compensation
922.623
922.623
2,758
0
0
Change in working capital
-508.945
-508.945
-1,024
552.978
76.282
Other working capital
-4,990
-4,990
-6,048
-767.311
-844.41
Other non-cash items
-85.4
-85.4
-10.733
-
-
Net cash provided by operating activities
-4,963
-4,963
-5,267
-767.311
-726.573
Cash flows from investing activities
Investments in property, plant and equipment
-27.392
-27.392
-780.876
-
-117.837
Purchases of investments
-10,000
-10,000
-10,000
0
0
Sales/maturities of investments
10,085
10,085
0
0
-
Net cash used for investing activities
58.978
58.978
-10,781
0
-117.837
Cash flows from financing activities
Common stock issued
0
0
22,673
0
0
Other financing activities
134.913
134.913
164
-172.314
-
Net cash used provided by (used for) financing activities
134.913
134.913
22,406
439.745
988.082
Net change in cash
-4,852
-4,852
6,358
-327.566
143.672
Cash at beginning of period
6,417
6,417
59.413
386.979
243.307
Cash at end of period
1,565
1,565
6,417
59.413
386.979
Free cash flow
Operating cash flow
-4,963
-4,963
-5,267
-767.311
-726.573
Capital expenditure
-27.392
-27.392
-780.876
-
-117.837
Free cash flow
-4,990
-4,990
-6,048
-767.311
-844.41